Lanoxin and Deafness bilateral - a phase IV clinical study of FDA data

Summary:

Deafness bilateral is reported as a side effect among people who take Lanoxin (digoxin), especially for people who are male, 60+ old, also take Peridex, and have Cardiac failure.

The phase IV clinical study analyzes which people have Deafness bilateral when taking Lanoxin. It is created by eHealthMe based on reports of 21,602 people who have side effects when taking Lanoxin from the FDA, and is updated regularly.

What is Lanoxin?

Lanoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 21,852 Lanoxin users. Check the latest studies of Lanoxin.

What is Deafness bilateral?

Deafness bilateral is found to be associated with 201 drugs and 748 conditions by eHealthMe. Check the latest studies of Deafness bilateral.

On Jul, 26, 2026

21,602 people reported to have side effects when taking Lanoxin.
Among them, 17 people (0.08%) have Deafness bilateral.

Among these 17 people:

What is the gender of people who have Deafness bilateral when taking Lanoxin? *

female: 11.76 %
male: 88.24 %

What is the age of people who have Deafness bilateral when taking Lanoxin? *

What are other drugs people take besides Lanoxin? *

What are other side effects people have besides Deafness bilateral? *

Hyperlipidaemia (presence of excess lipids in the blood): 16 people, 94.12%
Neuropathy Peripheral (surface nerve damage): 16 people, 94.12%
Metastases To Spine (cancer spreads to spine): 16 people, 94.12%
Metastases To Pelvis (cancer spreads to pelvis): 16 people, 94.12%
Metastases To Bone (cancer spreads to bone): 16 people, 94.12%
Kidney Stones: 16 people, 94.12%
Intervertebral Disc Degeneration (spinal disc degeneration): 16 people, 94.12%
Injury: 16 people, 94.12%
Hypotension (abnormally low blood pressure): 16 people, 94.12%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 16 people, 94.12%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 5.88%
Hepatitis C: 1 person, 5.88%
Cardiac Failure: 1 person, 5.88%

* Approximation only. Some reports may have incomplete information.

Do you take Lanoxin and have Deafness bilateral?

- Check whether Deafness bilateral is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Lanoxin:

Lanoxin (21,852 reports)

Browse all side effects of Lanoxin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Deafness bilateral:

Deafness bilateral (201 drugs)

Browse all the conditions that are associated with Deafness bilateral:

Deafness bilateral (748 conditions)

Related publications that referenced our studies

Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .

How the study uses the data?

The study uses data from the FDA. It is based on digoxin (the active ingredients of Lanoxin) and Lanoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.